Shanghai Henlius Biotech, Inc. (2696.HK)
HKD 23.9
(0.21%)
HKD 23.9
(0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.04 Billion | 981.62 Million | 90.39 Million | -609.58 Million | -443.12 Million | -52.17 Million |
| Net Income | 569.57 Million | -693.88 Million | -956.73 Million | -993.54 Million | -874.81 Million | -500.22 Million |
| Depreciation & Amortization | 359.23 Million | 277.6 Million | 200.17 Million | 135.77 Million | 82.49 Million | 42.96 Million |
| Deferred income taxes | 33.08 Million | - | 245.45 Million | 60.13 Million | 36.93 Million | -13.38 Million |
| Stock-based compensation | 2.58 Million | 12.51 Million | 48.41 Million | 35.73 Million | 97.11 Million | 71.68 Million |
| Change in working capital | -21.1 Million | 1.1 Billion | 511.13 Million | 115.66 Million | 152.99 Million | 302.38 Million |
| Other non-cash items | 104.54 Million | 284.7 Million | 41.95 Million | 36.65 Million | 62.13 Million | 44.38 Million |
| Investing Cash Flow | -1 Billion | -1.35 Billion | -1.68 Billion | -1.51 Billion | -1.13 Billion | -735.37 Million |
| Investments in PPE | -1.01 Billion | -1.36 Billion | -1.13 Billion | -1.51 Billion | -1.13 Billion | -735.37 Million |
| Acquisitions | -15 Million | - | - | - | - | - |
| Investment purchases | -120 Million | -550.61 Million | - | - | - | - |
| Sales/Maturities of investments | -537.74 Million | - | - | - | - | - |
| Other Investing Activities | 679.75 Million | 557.17 Million | -550.06 Million | 273 Thousand | -843.98 Million | -598.3 Million |
| Financing Cash Flow | 144.43 Million | 858.01 Million | 648.3 Million | 995.79 Million | 2.94 Billion | 1.67 Billion |
| Debt repayment | -2.14 Billion | -1.78 Billion | -1.29 Billion | -335.28 Million | -591.63 Million | -846.78 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 2.94 Billion | - |
| Other Financing Activities | -129.9 Million | 2.64 Billion | 1.94 Billion | 1.33 Billion | 589.77 Million | 2.52 Billion |
| Accounts receivables | -283.76 Million | -161.4 Million | -99.7 Million | -340.94 Million | -28.3 Million | 13.07 Million |
| Accounts payables | 283.76 Million | 161.4 Million | 99.7 Million | 340.94 Million | 28.3 Million | - |
| Inventory | -22.33 Million | -340.64 Million | -91.7 Million | -53.72 Million | -100.22 Million | -252 Thousand |
| Other working capital | 1.23 Million | 1.44 Billion | 602.83 Million | 169.39 Million | 253.21 Million | 302.64 Million |
| Cash at beginning of period | 673.47 Million | 154.98 Million | 1.11 Billion | 2.3 Billion | 958.99 Million | 58.51 Million |
| Cash at end of period | 867.66 Million | 673.47 Million | 154.98 Million | 1.11 Billion | 2.3 Billion | 958.99 Million |
| Capital Expenditure | -1.01 Billion | -1.36 Billion | -1.13 Billion | -1.51 Billion | -1.13 Billion | -735.37 Million |
| Effect of forex changes on cash | 6.27 Million | 37.58 Million | -16.76 Million | -60.74 Million | -29.73 Million | 8.92 Million |
| Net cash flow / Change in cash | 194.18 Million | 518.49 Million | -959.32 Million | -1.18 Billion | 1.34 Billion | 900.47 Million |
| Free Cash Flow | 36.47 Million | -383.67 Million | -1.04 Billion | -2.12 Billion | -1.57 Billion | -787.55 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 193.15 Million | 193.15 Million | 157.82 Million | 569.57 Million | 167.81 Million | 119.99 Million |
| Depreciation & Amortization | 86.3 Million | 86.3 Million | 115.67 Million | 359.23 Million | 81.07 Million | 81.23 Million |
| Deferred income taxes | - | - | - | 33.08 Million | - | 228 Million |
| Stock-based compensation | - | - | - | 2.58 Million | - | 1.29 Million |
| Change in working capital | -163.62 Million | -163.62 Million | 169.02 Million | -21.1 Million | -66.49 Million | -69.48 Million |
| Other non-cash items | 9.8 Million | 9.8 Million | 33.31 Million | 104.54 Million | 57.22 Million | 33.18 Million |
| Investing Cash Flow | -331.82 Million | -331.82 Million | -177.28 Million | -1 Billion | -283.25 Million | -271.95 Million |
| Investments in PPE | -51.84 Million | -51.84 Million | -184.28 Million | -1.01 Billion | -268.24 Million | -119.94 Million |
| Acquisitions | - | - | - | -15 Million | -15 Million | - |
| Investment purchases | - | - | - | -120 Million | - | - |
| Sales/Maturities of investments | - | - | - | -537.74 Million | - | - |
| Other Investing Activities | -279.98 Million | -279.98 Million | 6.99 Million | 679.75 Million | -6000.00 | -152 Million |
| Financing Cash Flow | -72.9 Million | -72.9 Million | -12.05 Million | 144.43 Million | -16 Thousand | 78.24 Million |
| Debt repayment | - | - | -520.35 Million | -2.14 Billion | -622.6 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -72.9 Million | -72.9 Million | -30.87 Million | -129.9 Million | 622.58 Million | 78.24 Million |
| Accounts receivables | -29.24 Million | -29.24 Million | 78.01 Million | -283.76 Million | 48.18 Million | -204.98 Million |
| Accounts payables | - | - | -78.01 Million | 283.76 Million | -48.18 Million | - |
| Inventory | -18.65 Million | -18.65 Million | 2.22 Million | -22.33 Million | 24.07 Million | -24.31 Million |
| Other working capital | -115.72 Million | -115.72 Million | 166.8 Million | 1.23 Million | -90.57 Million | 159.81 Million |
| Cash at beginning of period | - | 867.66 Million | 586.12 Million | 673.47 Million | 632.15 Million | - |
| Cash at end of period | -276.87 Million | 590.78 Million | 867.66 Million | 867.66 Million | 586.12 Million | -20.66 Million |
| Capital Expenditure | -51.84 Million | -51.84 Million | -184.28 Million | -1.01 Billion | -268.24 Million | -119.94 Million |
| Effect of forex changes on cash | 2.22 Million | 2.22 Million | -4.97 Million | 6.27 Million | -2.38 Million | 6.81 Million |
| Net cash flow / Change in cash | -276.87 Million | -276.87 Million | 281.54 Million | 194.18 Million | -46.03 Million | -20.66 Million |
| Free Cash Flow | 73.78 Million | 73.78 Million | 291.56 Million | 36.47 Million | -28.62 Million | 46.28 Million |
REFINE
LRD
CSBBANK
QUIK
0A0L
NARRF